Met Life Investment Management, LLC Epizyme, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.6 Billion
  • Q2 2024

Shares

48 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$1.06 - $2.68 $6,849 - $17,318
-6,462 Closed
0 $0
Q4 2021

May 17, 2024
SELL
$2.5 - $5.19 $65,915 - $136,839
-26,366 Reduced 80.32%
6,462 $16,000
Q4 2021

Jun 21, 2023
BUY
$2.5 - $5.19 $16,155 - $33,537
6,462 New
6,462 $16,000
Q4 2021

Mar 22, 2023
SELL
$2.5 - $5.19 $65,915 - $136,839
-26,366 Reduced 80.32%
6,462 $16,000
Q4 2021

Feb 15, 2022
SELL
$2.5 - $5.19 $65,915 - $136,839
-26,366 Reduced 80.32%
6,462 $16,000
Q3 2021

May 17, 2024
BUY
$4.82 - $8.46 $44,956 - $78,906
9,327 Added 39.69%
32,828 $168,000
Q3 2021

Jun 21, 2023
BUY
$4.82 - $8.46 $158,230 - $277,724
32,828 New
32,828 $168,000
Q3 2021

Mar 22, 2023
BUY
$4.82 - $8.46 $44,956 - $78,906
9,327 Added 39.69%
32,828 $168,000
Q3 2021

Nov 15, 2021
BUY
$4.82 - $8.46 $44,956 - $78,906
9,327 Added 39.69%
32,828 $168,000
Q2 2021

May 17, 2024
SELL
$6.81 - $9.71 $84,083 - $119,889
-12,347 Reduced 34.44%
23,501 $195,000
Q2 2021

Jun 21, 2023
BUY
$6.81 - $9.71 $160,041 - $228,194
23,501 New
23,501 $195,000
Q2 2021

Mar 22, 2023
SELL
$6.81 - $9.71 $84,083 - $119,889
-12,347 Reduced 34.44%
23,501 $195,000
Q2 2021

Aug 16, 2021
SELL
$6.81 - $9.71 $84,083 - $119,889
-12,347 Reduced 34.44%
23,501 $195,000
Q1 2021

May 17, 2024
BUY
$7.45 - $12.32 $267,067 - $441,647
35,848 New
35,848 $312,000
Q1 2021

Jun 26, 2023
BUY
$7.45 - $12.32 $267,067 - $441,647
35,848 New
35,848 $312 Million
Q1 2021

Mar 22, 2023
BUY
$7.45 - $12.32 $32,407 - $53,592
4,350 Added 13.81%
35,848 $312,000
Q1 2021

May 14, 2021
BUY
$7.45 - $12.32 $32,407 - $53,592
4,350 Added 13.81%
35,848 $312,000
Q4 2020

May 24, 2024
SELL
$10.34 - $13.77 $87,600 - $116,659
-8,472 Reduced 21.2%
31,498 $342,000
Q4 2020

Jun 22, 2023
BUY
$10.34 - $13.77 $325,689 - $433,727
31,498 New
31,498 $342,000
Q4 2020

Mar 22, 2023
SELL
$10.34 - $13.77 $87,600 - $116,659
-8,472 Reduced 21.2%
31,498 $342,000
Q4 2020

Feb 16, 2021
SELL
$10.34 - $13.77 $87,600 - $116,659
-8,472 Reduced 21.2%
31,498 $342,000
Q3 2020

May 24, 2024
SELL
$11.73 - $16.25 $108,596 - $150,442
-9,258 Reduced 18.81%
39,970 $477 Million
Q3 2020

Jun 26, 2023
BUY
$11.73 - $16.25 $468,848 - $649,512
39,970 New
39,970 $476,000
Q3 2020

Mar 22, 2023
SELL
$11.73 - $16.25 $108,596 - $150,442
-9,258 Reduced 18.81%
39,970 $476,000
Q3 2020

Nov 13, 2020
SELL
$11.73 - $16.25 $108,596 - $150,442
-9,258 Reduced 18.81%
39,970 $477,000
Q2 2020

May 24, 2024
BUY
$13.68 - $20.46 $673,439 - $1.01 Million
49,228 New
49,228 $791 Million
Q2 2020

Jun 26, 2023
BUY
$13.68 - $20.46 $673,439 - $1.01 Million
49,228 New
49,228 $790,000
Q2 2020

Mar 22, 2023
BUY
$13.68 - $20.46 $230,412 - $344,607
16,843 Added 52.01%
49,228 $790,000
Q2 2020

Aug 14, 2020
BUY
$13.68 - $20.46 $230,412 - $344,607
16,843 Added 52.01%
49,228 $791,000
Q1 2020

Jul 12, 2023
BUY
$14.83 - $26.72 $480,269 - $865,327
32,385 New
32,385 $502,000
Q1 2020

Mar 22, 2023
SELL
$14.83 - $26.72 $56,902 - $102,524
-3,837 Reduced 10.59%
32,385 $502,000
Q1 2020

May 15, 2020
SELL
$14.83 - $26.72 $56,902 - $102,524
-3,837 Reduced 10.59%
32,385 $502,000
Q4 2019

Jul 12, 2023
BUY
$9.77 - $24.6 $353,888 - $891,061
36,222 New
36,222 $891,000
Q3 2019

Jul 12, 2023
BUY
$10.17 - $13.86 $368,377 - $502,036
36,222 New
36,222 $373,000
Q3 2019

Mar 22, 2023
BUY
$10.17 - $13.86 $5,827 - $7,941
573 Added 1.61%
36,222 $373,000
Q3 2019

Nov 14, 2019
BUY
$10.17 - $13.86 $5,827 - $7,941
573 Added 1.61%
36,222 $374,000
Q2 2019

Jul 12, 2023
BUY
$11.43 - $15.12 $534,878 - $707,555
46,796 New
46,796 $587,000
Q2 2019

Mar 22, 2023
BUY
$11.43 - $15.12 $120,860 - $159,878
10,574 Added 42.17%
35,649 $447,000
Q2 2019

Aug 14, 2019
BUY
$11.43 - $15.12 $120,860 - $159,878
10,574 Added 42.17%
35,649 $447,000
Q1 2019

Jul 13, 2023
BUY
$5.98 - $13.98 $149,948 - $350,548
25,075 New
25,075 $310,000
Q4 2018

Jul 13, 2023
BUY
$5.22 - $10.44 $130,891 - $261,783
25,075 New
25,075 $154,000
Q4 2018

Mar 22, 2023
SELL
$5.22 - $10.44 $66,100 - $132,201
-12,663 Reduced 33.56%
25,075 $154,000
Q4 2018

Feb 14, 2019
SELL
$5.22 - $10.44 $66,100 - $132,201
-12,663 Reduced 33.56%
25,075 $154,000
Q3 2018

Jul 13, 2023
BUY
$9.5 - $13.75 $238,212 - $344,781
25,075 New
25,075 $265,000
Q3 2018

Mar 22, 2023
BUY
$9.5 - $13.75 $358,511 - $518,897
37,738 New
37,738 $400,000
Q3 2018

Nov 14, 2018
BUY
$9.5 - $13.75 $120,298 - $174,116
12,663 Added 50.5%
37,738 $400,000
Q2 2018

Aug 15, 2018
BUY
$12.85 - $18.45 $53,391 - $76,659
4,155 Added 19.86%
25,075 $340,000
Q4 2017

Feb 15, 2018
BUY
$11.55 - $20.1 $241,626 - $420,492
20,920
20,920 $263,000

About Epizyme, Inc.

EPZM Quotes by TradingView
  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email